Skip to search formSkip to main contentSkip to account menu

Ki 1769

Known as: 3-Pyridinecarboximidamide, N-cyano-N'-(2-phenylethyl)-, Ki-1769, Ki1769 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Pyridines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1999
1999
Effect of K+ channel openers, KRN2391 and Ki1769, and nitroglycerin on the urinary tract of rats in vivo.
The effects of KRN2391 (N-cyano-N'-(nitroxyethyl)-3-pyridine carboximidamide methane-sulfonate), which possesses ATP-sensitive… 
1997
1997
In vitro and in vivo vasodilating effects of KRN4884, Ki1769 and Ki3005, pyridinecarboxamidine derivatives
Summary— The vasodilating potencies and mechanism of action of a novel pyridinecarboxamidine derivative, KRN4884 (5‐amino‐N‐(2‐(2… 
1994
1994
Comparative analysis of vasodilating mechanisms of Ki1769, Ki3315 and KRN2391, pyridinecarboximidamide derivatives, in porcine isolated coronary artery.
1994
1994
Characteristics of Ki1769, a novel vasodilator, in isolated rat aorta.
The vasorelaxant mechanism of a newly synthesized vasodilator, Ki1769 [N-cyano-N'-(2-phenethyl)-3-pyridinecarboximidamide], was… 
1994
1994
Comparison of coronary dilating effects of Ki1769, a new K channel opener of the pyridinecarboximidamide type, and nifedipine in anesthetized dogs.
The coronary dilating effect of a new type of K channel opener, N-cyano-N'-(2-phenethyl)-3-pyridinecarboximidamide (Ki1769), was… 
1993
1993
Vasorelaxant action of Ki1769, a new pyridinecarboximidamide, in isolated porcine coronary artery.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)